Calcium channel blockers

Mechanism of Action:

  • Block L-type calcium channels in vascular smooth muscle and cardiac myocytes.
  • Results in:
    • Vasodilation: Lowers BP (DHPs)
    • Decreased contractility & heart rate: Benefits angina & heart failure (non-DHPs)

Clinical Uses:

  • Hypertension (DHPs): Amlodipine, nifedipine, felodipine (1st line for most)
  • Angina (non-DHPs): Verapamil, diltiazem
  • Supraventricular arrhythmias (non-DHPs): Verapamil (e.g., atrial fibrillation)
  • Raynaud’s phenomenon (DHPs): Nifedipine

Adverse Effects:

  • Common: Dizziness, fatigue, headache, flushing, ankle swelling (generally mild)
  • Non-DHP specific: Bradycardia & heart failure (susceptible individuals)

Contraindications:

  • Severe heart failure
  • Sick sinus syndrome
  • Advanced atrioventricular block

Key Points:

  • Choose based on indication & patient.
  • DHPs are generally well-tolerated, non-DHPs require caution in specific populations.
  • Monitor for drug interactions.
  • Stay updated on evolving roles in cardiovascular medicine.